Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Sterling steadies vs dollar, euro after profit-taking knock

Thu, 08th Apr 2021 12:38

* Pound edges up vs dollar, flat vs sterling

* Graphic: World FX rates in 2021 http://tmsnrt.rs/2egbfVh

* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv
(Updates prices)

By Tom Wilson

LONDON, April 8 (Reuters) - Sterling steadied against the
dollar and euro on Thursday, recovering after a bruising bout of
profit-taking earlier in the week.

The pound fell 1.2% against the dollar and 1.7% against the
euro between Tuesday and Wednesday as investors took cash off
the table after a strong first quarter for the British currency.

But by 1500 GMT on Thursday, sterling was up 0.15% against
the dollar at $1.3760, after touching its lowest this
month earlier in the day as the dollar traded near its lowest in
two weeks versus major peers.

Against the euro, the pound fell 0.1% to 86.49 pence per
euro, following two days of losses against the
single currency since September - a fall traders said was
amplified by a squeeze of euro-pound short positions.

Traders were largely optimistic over the pound's near-term
prospects after a strong start to the year. But some urged
caution as markets have already priced in positive news for
sterling.

Sterling's pullback was "exaggerated," ING analysts wrote,
adding that they were "constructive" on the pound, citing
Britain's relatively fast COVID-19 vaccine programme.

Expectations of an economic rebound in Britain, spurred by
rapid vaccinations, helped sterling to record its best quarter
since 2015 versus the euro. Falling expectations of negative
interest rates also helped.

Britain has surged ahead of the rest of Europe in the race
to inoculate its population, with almost half of its citizens
receiving a first dose. But supply issues from its main
Oxford-AstraZeneca vaccine have slowed progress in
recent days.

Some market players said the pound may struggle to maintain
its strong start to the year.

"We are starting what's likely to be much more challenging
quarter for sterling," said Adam Cole, chief currency strategist
at RBC Capital Markets, with positive news on vaccines and the
lower risk of negative rates already priced in.

Others said Britain's economic performance in the next
quarter would be a key factor. With infection numbers falling, a
planned partial re-opening of the economy is due next week.

"For there to be follow through, we actually need to see the
data outperform even expectations," said Stephen Gallo, European
head of FX strategy at BMO Capital Markets.
(Reporting by Tom Wilson;
editing by Mark Heinrich, Chizu Nomiyama, Larry King)

More News
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.